Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel

Journal of Vascular and Interventional Radiology

Volumn 13, Issue 7, 2002, Pages 703-707

  Celletti, Francesca L ^a   Waugh, Jacob M ^a   Amabile, Philippe G ^a   Kao, Ed Y ^a   Boroumand, Sara ^a   Dake, Michael D ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis, therapeutic; Angiostatin; Paclitaxel; Vascular endothelial growth factor

Indexed keywords

ANGIOSTATIN; PACLITAXEL; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GROWTH INHIBITION; MACROPHAGE ACTIVATION; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; RABBIT; REVASCULARIZATION; STEM CELL; VASCULAR RESISTANCE;

EID: 0036079448     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)61847-8     Document Type: Article

References (29)

1. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
2. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery diseases
3. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
4. Vascular permeability factor, an endothelial cell mitogen related to PDGF
5. Vascular endothelial growth factor is a secreted angiogenic mitogen
6. Localization of PDGF-B protein in macrophages in all phases of atherogenesis
7. The pathogenesis of atherosclerosis: A perspective for the 1990s
8. Human atherosclerosis: II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions
9. Capillary rupture with intimal hemorrhage as a causative factors in coronary thrombosis
10. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia
11. Vasa Vasorum in atherosclerotic coronary arteries: Responses to vasoactive stimuli and regression of atherosclerosis
12. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice
13. Vascular endothelial growth factor enhances atherosclerotic plaque progression
14. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque
15. VEGF administration in chronic myocardial ischemia in pigs
16. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
17. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery
18. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
19. Atherosclerosis and angiogenesis: Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor
20. Angiostatin induces and sustains dormancy of human primary tumors in mice
21. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
22. Endothelial progenitors cells as putative targets for angiostatin
23. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with mitosis arrest
24. Isolation of putative progenitor endothelial cells for angiogenesis
25. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitors cells
26. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes
27. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque
28. Activated macrophages induce vascular proliferation
29. Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages